Clinical Trial Update: A Novel Echocardiography-Guided Strategy for Percutateous Closure of Atrial Septal Defect Assisted by PannaWire [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update describing a novel echocardiography-guided percutaneous closure strategy for atrial septal defect using the PannaWire device.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Septal Defect

Drugs mentioned

• PannaWire

Snippet

Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital | Conditions: Atrial Septal Defect (ASD) | Phase 4 | Status: NOT_YET_RECRUITING